The University of Colorado Division of Hematology will be hosting a review of the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in Denver on January 27, 2017.
Promising approach unleashes modified T-cells to battle acute lymphoblastic leukemia.
“If you’re working under a constant state of emergency, you become stressed and less effective. I think of blood stem cells in the same way,” Pietras says.
Dr. Daniel Sherbenou, MD, PhD, a recently recruited faculty member in the Hematology Division, was honored with a Young Investigator Award from the National Comprehensive Cancer Network (NCCN).